Tags » Designation

A Brief Introduction to Historic Power Stations

Coal fuelled Britain’s industrial revolution from the late-18th century. It also fired the so-called second industrial revolution when new technologies like electricity and electrical communications propelled us into the 20th century. 685 more words

Designation

Day 19: Of Designations and Grades

Its funny how when you’re working for a company, everything about you is defined by it. Your office desk, your friends, your pay check and hence your car. 410 more words

Ambition

Heritage Pub Quiz: Celebrating Great Inter-War Pubs

A handful of England’s best inter-war pubs, built between 1918 and 1939, have just been listed following Historic England’s research.

They were rebuilt during the “improved” pub movement when breweries tried to appeal to more respectable customers, including families and women. 438 more words

Designation

England's Record Breaking Heritage

The Guinness World Records celebrates 60 years of extraordinary achievements this week, from globetrotting explorers to sports heroes smashing records.

In this spirit, we’ve delved into our… 908 more words

Designation

Thakoon for DesigNation 2015

I have to admit, I have never shopped at Kohl’s or stepped into one of their retail stores before, but American designer Thakoon Panichgul will have a limited-edition clothing line for Kohl’s DesigNation 2015.  51 more words

Fashion

P8 - The Evergreen Inferno

Yesterday I gave my P8 speech at Bombay Toastmasters. The objectives of P8 are:

  1. Select visual aids that are appropriate for your message and the audience.
  2. 683 more words
My Posts

Soligenix Receives Orphan Drug Designation from the European Commission for SGX301 as a Treatment for Cutaneous T-Cell Lymphoma

PRINCETON, N.J., Aug. 4, 2015, SNGX, OTCQB /PRNewswire/ Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that the European Commission, acting on the positive recommendation from the European Medicines Agency (EMA) Committee for Orphan Medicinal Products (COMP), has granted orphan drug designation to synthetic hypericin (the active pharmaceutical ingredient in SGX301) for the treatment of cutaneous T-cell lymphoma (CTCL), a rare disease and a class of non-Hodgkin s lymphoma, a type of cancer of the white blood cells that are an integral part of the immune system. 45 more words